TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Participants Experiencing Dose Limiting Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Level of androgens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in hydration status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects With Histopathologically-confirmed CIN2+ and/or VIN2+ and/or VaIN2+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Subjects With HPV-16 and/or -18 persistent cervical infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of participants with PGT121 mAb reactogenicity, related AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of intraabdominal hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of abdominal compartment syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants With Best Overall Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MRI Erosion Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Summarized change of FACT-G score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: overall survival rate of preformed metal crowns
Endpoint domain: Mortality/survival
Primary endpoint: Serum Carotenoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of Radio-Wave imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: HR-HPV persistent infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of rDEN2Δ30-7169-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Dengue virus neutralizing antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: EQ Visual Analog Scale (EQVAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Kansas City Cardiomyopathy Questionnaire (KCCQ), Overall Summary Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Significant Clinical or Neurological Effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Growth Velocity (Centimeter Per Year)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient being completely free of tearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Percent Change in Triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Percent Change in High-Density Lipoprotein Cholesterol (HDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in daily energy intake (kcal per day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in physical activity (minutes/week)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete molecular response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in risk score (NORRISK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International clinical score Daniels and Worthingham
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifetime prevalence of prepubertal gynecomastia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Lifetime prevalence of precocious puberty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Endocrine Disruption - Comparison between exposed and unexposed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Self-Ratings of Thought Appraisals (Believability)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Ratings of Thought Appraisals (Negativity)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Ratings of Thought Appraisals (Discomfort)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Ratings of Thought Appraisals (Willingness)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Ratings of Thought Appraisals (Avoidance)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety and tolerance of Vedolizumab
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Fold Ratio (GMFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion (SCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Taste and Flavor Intensity Ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of Salivary Proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composition of Oral Microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Feasible Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Induction protocol type
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cases with Postdural puncture headache
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiac conduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Parent-Adolescent Communication about Sex and Contraception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Score in a Quality of life assessment Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Dim Light Melatonin Onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mucociliary Clearance Rate (MCC60)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes on Psychomotor Performance (Continuous Tracking Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Cognitive Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in driving performance (simulated)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Hepatic Steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Hoehn and Yahr Staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Time from door to drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Time from Door to Tici 2c/3 flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Time from Door to Administration of Reversal Agent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximal Change in Forced Expiratory Volume in One Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Survival proportion
Endpoint domain: Mortality/survival
Primary endpoint: Health-related quality of life after limb salvage
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Assessment of the functional ability after limb salvage
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Multiple organs function score (MODS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of CD162 expression on monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pulse wave measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of children reached with single-dose azithromycin
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HDL-cholesterol Level After 3 Months of Rosuvastatin Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LDL-cholesterol Level After 3 Months of Rosuvastatin Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Patients Who Reached Target Level of LDL-cholesterol After 3 Months of Rosuvastatin Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-HG concentration in surgically resected tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in the Crohn's Disease Endoscopic Index of Severity (CDEIS) Blinded Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Serum High Sensitivity C-reactive Protein (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Stool Calprotectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repigmentation (more than 50% from baseline)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Everolimus aim response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Carboxyhaemoglobin concentration in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Urinary excretion of S-phenylmercapturic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary excretion of NNAL and NNAL-glucuronides (total NNAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SENP1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: range of motion of the hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: pressure on back that causes pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death rate with all causes mortality
Endpoint domain: Mortality/survival
Primary endpoint: Hemorrhages
Endpoint domain: Adverse events/effects
Primary endpoint: Gravimetric measurement of sweat production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of ICU Patients Who Acquire VRE or MRSA
Endpoint domain: Adverse events/effects
Primary endpoint: Global Health Status Physical Health Mean T-Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global Health Status Mental Health Mean T-Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fatigue Mean T-score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in diabetes-related health outcomes as measured by hemoglobin A1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in diabetes-related health outcomes as measured by body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in diabetes-related health outcomes as measured by waist circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complete or clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient reported pain levels
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Moderate or severe cerebral palsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BARC 2,3 and 5 bleeding or vascular complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Cumulative Number of Subjects With Adverse Events Indicating Possible Mechanical Failure or Weakness of the HAV
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Baseline Change of Panel Reactive Antibody (PRA) Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Primary Patency, Primary Assisted Patency and Secondary Patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Complete Thrombotic Microangiopathy (TMA) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of Pressure (COP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implant Stability Quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Tolerability assessed by SAFTEE
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Average Visual Analog Scale (VAS) Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Lens Comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Identification of biomarkers for early diagnosis of pancreatic cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical Pain Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment-Emergent Severe Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: residual myometrial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success and cure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in position and shape of the tumour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Healthy, Well-being and Aging
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of RO7017773 in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of enrolment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of study completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Stress measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants with Treatment Related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of thyroid dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Duration of Procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in the number of oral, vaginal, and/or anal sex episodes without a condom
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in the number of vaginal sex episodes without any form of contraception
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in self-efficacy for communicating with sexual partners about sexual and reproductive health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Numeric Rating Scale for pain and anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vein Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Proportion of Participants With Confirmed Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in psychological and physical symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complete Response + Partial Response + Stable Disease > 24 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients undergoing surgical resection after neoadjuvant treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of the sensory and motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between Bispectral Index and Neurosense indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective adaptation to changes after ostomy surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bursting pressures in human vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: filter survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-relapse Mortality (NRM) at Day 100
Endpoint domain: Mortality/survival
Primary endpoint: Laboratory Variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxicity within 60 days
Endpoint domain: Adverse events/effects
Primary endpoint: cognitive deterioration (HVLT delayed recall)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Clotting of Extracorporeal Dialysis Circuit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of AGYW with a sexually transmitted infection (STI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of AGYW who complete HIV testing and counseling (HTC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of AGYW who elect to take pre-exposure prophylaxis (PrEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real Time Elastography result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial Resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scan coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean contrast-to-noise ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of liver decompensation
Endpoint domain: Mortality/survival
Primary endpoint: Fatty acid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anti-Xa activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMC of anti-BPT Ab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of any clinical relevant findings in ECG variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pharmacokinetics of amantadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of oseltamivir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Change From Baseline in Sleep Efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: kidney radiation dosimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: intracranial progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Bowel Habit Diary changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of patients with congenital heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in time for the timed get up and go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy Analysis (Merz Validated Hand Grading Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ratingen score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: central obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change of visual acuity for the total patient population
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with asparagine depletion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axis orientation of DT1 toric lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving ASAS40 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum sodium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: bilateral absence of the cortical SSEP response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 6 Minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes